Discgenics Is A Clinical Stage Biopharmaceutical Company Based In Utahfocused On Developing Regenerative Cell Based Therapies For Degenerative Diseases Of The Spinefounded In 2008 By Drvalery Kukekov And Drkevin Foleythe Company Aims To Alleviate Pain And Restore Function For Patients Suffering From These Conditions The Company S Primary Product Candidate Is Idctan Injectable Cell Therapy That Uses Proprietary Discogenic Cells To Treat Mild To Moderate Degenerative Disc Diseaseidct Is Currently Investigational And Has Not Yet Received Approval From Regulatory Agenciesdiscgenics Is Committed To High Quality Standards And Innovationstriving To Improve The Lives Of Those Affected By Chronic Back Painthe Company Has Been Recognized For Its Contributions To Spinal Therapeuticsincluding Being Named One Of The Top 100 Companies In North America By Red Herring In 2014
